[
  {
    "ts": null,
    "headline": "Will Caremark’s New Wegovy Copay Program Redefine CVS Health’s (CVS) Approach to Cost and Access?",
    "summary": "In the past week, CVS Health's pharmacy benefit manager Caremark announced a new $200 copay program for Novo Nordisk's weight-loss drug Wegovy, aiming to expand insurance coverage and lower costs for health plans starting in 2026. This move prioritizes Wegovy over Eli Lilly’s Zepbound and could generate multibillion-dollar savings by using negotiated rebates and pricing strategies to benefit both patients and insurers. Caremark’s initiative not only addresses rising drug costs but also...",
    "url": "https://finnhub.io/api/news?id=cc9815161b6d57f578f1dbd0bcda940078868d8fd4e424cda846913ecdc65780",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759586406,
      "headline": "Will Caremark’s New Wegovy Copay Program Redefine CVS Health’s (CVS) Approach to Cost and Access?",
      "id": 136980571,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "In the past week, CVS Health's pharmacy benefit manager Caremark announced a new $200 copay program for Novo Nordisk's weight-loss drug Wegovy, aiming to expand insurance coverage and lower costs for health plans starting in 2026. This move prioritizes Wegovy over Eli Lilly’s Zepbound and could generate multibillion-dollar savings by using negotiated rebates and pricing strategies to benefit both patients and insurers. Caremark’s initiative not only addresses rising drug costs but also...",
      "url": "https://finnhub.io/api/news?id=cc9815161b6d57f578f1dbd0bcda940078868d8fd4e424cda846913ecdc65780"
    }
  }
]